| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Allosterically activating SHP2 by oleanolic acid inhibits STAT3–Th17 axis for ameliorating colitis
|
Hu, Jinbo
|
|
|
14 |
6 |
p. 2598-2612
|
article
|
| 2 |
An emerging terpolymeric nanoparticle pore former as an internal recrystallization inhibitor of celecoxib in controlled release amorphous solid dispersion beads: Experimental studies and molecular dynamics analysis
|
Lugtu-Pe, Jamie Anne
|
|
|
14 |
6 |
p. 2669-2684
|
article
|
| 3 |
Author correction to ‘FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis’ [Acta Pharm Sin B 14 (2024) 1605–1623]
|
Huang, Zhifeng
|
|
|
14 |
6 |
p. 2791-2793
|
article
|
| 4 |
Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ [Acta Pharm Sin B 11 (2021) 420–433]
|
Shang, Pengzhao
|
|
|
14 |
6 |
p. 2790
|
article
|
| 5 |
Carrimycin inhibits coronavirus replication by decreasing the efficiency of programmed –1 ribosomal frameshifting through directly binding to the RNA pseudoknot of viral frameshift-stimulatory element
|
Li, Hongying
|
|
|
14 |
6 |
p. 2567-2580
|
article
|
| 6 |
Ciclopirox inhibits SARS-CoV-2 replication by promoting the degradation of the nucleocapsid protein
|
Wei, Xiafei
|
|
|
14 |
6 |
p. 2505-2519
|
article
|
| 7 |
Cisplatin-based miRNA delivery strategy inspired by the circCPNE1/miR-330-3p pathway for oral squamous cell carcinoma
|
Fan, Hua-yang
|
|
|
14 |
6 |
p. 2748-2760
|
article
|
| 8 |
Computer-aided molecular design and optimization of potent inhibitors disrupting APC‒Asef interaction
|
Wang, Xuefei
|
|
|
14 |
6 |
p. 2631-2645
|
article
|
| 9 |
Cover Story
|
|
|
|
14 |
6 |
p. xii
|
article
|
| 10 |
Di-PEGylated insulin: A long-acting insulin conjugate with superior safety in reducing hypoglycemic events
|
Zeng, Zhipeng
|
|
|
14 |
6 |
p. 2761-2772
|
article
|
| 11 |
Directly targeting BAX for drug discovery: Therapeutic opportunities and challenges
|
Zhang, Zhenwei
|
|
|
14 |
6 |
p. 2378-2401
|
article
|
| 12 |
Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches
|
Elzoghby, Ahmed O.
|
|
|
14 |
6 |
p. 2475-2504
|
article
|
| 13 |
Enhanced optical imaging and fluorescent labeling for visualizing drug molecules within living organisms
|
Sun, Ting
|
|
|
14 |
6 |
p. 2428-2446
|
article
|
| 14 |
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
|
Huang, Xiaowei
|
|
|
14 |
6 |
p. 2402-2427
|
article
|
| 15 |
Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits
|
Xiao, Bo
|
|
|
14 |
6 |
p. 2732-2747
|
article
|
| 16 |
Genome mining of sulfonated lanthipeptides reveals unique cyclic peptide sulfotransferases
|
Wang, Meng
|
|
|
14 |
6 |
p. 2773-2785
|
article
|
| 17 |
(+)/(−)-Gerbeloid A, a pair of unprecedented coumarin-based polycyclic meroterpenoid enantiomers from Gerbera piloselloides: Structural elucidation, semi-synthesis, and lipid-lowering activity
|
Zhao, Chenxu
|
|
|
14 |
6 |
p. 2657-2668
|
article
|
| 18 |
Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling
|
He, Xuemin
|
|
|
14 |
6 |
p. 2613-2630
|
article
|
| 19 |
Idebenone alleviates doxorubicin-induced cardiotoxicity by stabilizing FSP1 to inhibit ferroptosis
|
Qiu, Hongliang
|
|
|
14 |
6 |
p. 2581-2597
|
article
|
| 20 |
Interferon-induced MXB protein restricts vimentin-dependent viral infection
|
Yi, Dongrong
|
|
|
14 |
6 |
p. 2520-2536
|
article
|
| 21 |
Nanoparticle drug delivery system for the treatment of brain tumors: Breaching the blood–brain barrier
|
Tang, Qiyu
|
|
|
14 |
6 |
p. 2786-2789
|
article
|
| 22 |
Nanotherapeutics targeting autophagy regulation for improved cancer therapy
|
Liu, Yunmeng
|
|
|
14 |
6 |
p. 2447-2474
|
article
|
| 23 |
Pharmacokinetic enhancement of oncolytic virus M1 by inhibiting JAK‒STAT pathway
|
Tan, Jingyi
|
|
|
14 |
6 |
p. 2554-2566
|
article
|
| 24 |
Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer
|
Gao, Fangyan
|
|
|
14 |
6 |
p. 2685-2697
|
article
|
| 25 |
Repurposing disulfiram with CuET nanocrystals: Enhancing anti-pyroptotic effect through NLRP3 inflammasome inhibition for treating inflammatory bowel diseases
|
Xu, Xueming
|
|
|
14 |
6 |
p. 2698-2715
|
article
|
| 26 |
Spirohypertones A and B as potent antipsoriatics: Tumor necrosis factor-α inhibitors with unprecedented chemical architectures
|
Duan, Yulin
|
|
|
14 |
6 |
p. 2646-2656
|
article
|
| 27 |
Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy
|
Qin, Xiaojing
|
|
|
14 |
6 |
p. 2361-2377
|
article
|
| 28 |
Suppressing Wnt signaling of the blood‒tumor barrier to intensify drug delivery and inhibit lipogenesis of brain metastases
|
Tong, Yang
|
|
|
14 |
6 |
p. 2716-2731
|
article
|
| 29 |
Table of Contents
|
|
|
|
14 |
6 |
p. iii-xi
|
article
|
| 30 |
Transient induction of actin cytoskeletal remodeling associated with dedifferentiation, proliferation, and redifferentiation stimulates cardiac regeneration
|
Fu, Wenbin
|
|
|
14 |
6 |
p. 2537-2553
|
article
|
Journal description